Literature DB >> 2880796

Synthetic sulpholipopolysaccharides: novel adjuvants for humoral immune responses.

L A Hilgers, H Snippe, M Jansze, J M Willers.   

Abstract

Referring to the strong immunostimulating activity of combinations of lipophilic agents and dextran sulphate, conjugates with chemical determinants of both types of adjuvants were synthesized and then examined for immunostimulatory capabilities in mice. Saturated fatty acids with varying chain lengths and sulphate groups were coupled covalently at defined ratios to the polysaccharide Ficoll (MW 400,000). Chemical analysis of 60 of the sulpholipopolysaccharides synthesized revealed that the number of sulphate groups per monosaccharide unit varied from 0 to 1.6, and the number of lipid groups from 0 to 0.8. Adjuvanticity of these conjugates for the humoral immune response was determined using sheep red blood cells (SRBC) and dinitrophenyl-haptenated bovine serum albumin (DNP-BSA) as antigens. Five days after intraperitoneal injection of adjuvant and antigen, the numbers of direct anti-SRBC plaque-forming cells (PFC) in the spleen were determined. Anti-DNP antibody titres were measured from 1 to 4 weeks after immunization. PFC responses to 2 X 10(6) SRBC were augmented up to a 100-fold by conjugates of Ficoll and sulphate (sulphopolysaccharides: SPs) or lipid groups (lipopolysaccharides: LPs). Introduction of low or moderate numbers of lipid groups in SPs reduced adjuvanticity. Adjuvant activity of sulpholipopolysaccharides (SLPs) with varying sulphate and high lipid content depended on the sulphate contents and the chain length of the lipids. Sulphate reduced adjuvanticity of the SLPs, and the number of sulphate groups required for complete annihilation increased with the chain length of the lipid. LPs and SLPs, including conjugates that did not enhance anti-SRBC PFC responses, augmented serum antibody responses to DNP-BSA while SPs were hardly effective.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2880796      PMCID: PMC1453343     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  Killed Listeria monocytogenes vaccine becomes protective on addition of polyanions.

Authors:  C Van Der Meer; F M Hofhuis; J M Willers
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

Review 2.  Synthetic vaccines.

Authors:  R Arnon; M Shapira; C O Jacob
Journal:  J Immunol Methods       Date:  1983-07-29       Impact factor: 2.303

3.  Enhancement of delayed-type hypersensitivity and induction of interferon by the lipophilic agents DDA and CP-20,961.

Authors:  C A Kraaijeveld; H Snippe; T Harmsen; B Benaissa-Trouw
Journal:  Cell Immunol       Date:  1982-12       Impact factor: 4.868

4.  Adjuvanticity of Evans blue dye: preliminary characterization of its mechanisms and mode of application in mice.

Authors:  M P Arora; A J Crowle
Journal:  J Reticuloendothel Soc       Date:  1978-09

Review 5.  Newer directions in vaccine development and utilization.

Authors:  M R Hilleman
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

6.  Combinations of two synthetic adjuvants: synergistic effects of a surfactant and a polyanion on the humoral immune response.

Authors:  L A Hilgers; H Snippe; M Jansze; J M Willers
Journal:  Cell Immunol       Date:  1985-05       Impact factor: 4.868

7.  Maltose tetrapalmitate, a nontoxic immunopotentiator with antitumor activity.

Authors:  V N Nigam; C A Brailovsky; C Chopra
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

8.  Saponin and other haemolysins (vitamin A, aliphatic amines, polyene antibiotics) as adjuvants for SRBC in the mouse. Evidence for a role for cholesterol-binding in saponin adjuvanticity.

Authors:  R Bomford
Journal:  Int Arch Allergy Appl Immunol       Date:  1980

9.  Hapten-specific hemolytic plaque assays usually fail to detect most of the diversity in the anti-hapten response.

Authors:  B Merchant; J K Inman
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

10.  Effects of structural variations in synthetic glycolipids upon mitogenicity for spleen lymphocytes, adjuvancy for humoral immune response and on anti-tumour potential.

Authors:  V N Nigam; J Bonaventure; C Chopra; C A Brailovsky
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.